PGP and neoplasm: Compounds 2, 3, and 4 also enhanced the cytotoxicity of several P-gp substrates including colchicine, vinblastine, and paclitaxel, and reversed the MDR-phenotype in P-gp-overexpressing MDR KB-C2 tumor cells, in a dose-dependent manner [45].